ONTARIO, Calif.–(BUSINESS WIRE)–Prime Healthcare Services will report earnings the morning of August 12th, 2025, to be followed by a conference call at 2:00 p.m. (ET) to discuss the reported results. Please ensure you pre-register prior to the call by emailing EGarcia27@primehealthcare.com to facilitate attaining your individual pin that will allow direct access to the call. … [Read more…]
Paubox survey reveals rural providers are struggling with every major challenge—from staffing to infrastructure—as cyber threats rise SAN FRANCISCO–(BUSINESS WIRE)–#emailsecurity–As cyber threats grow more frequent and sophisticated, rural hospitals and clinics face challenges on all fronts—tight budgets, limited staff, inadequate training, complex technology, and unsupportive vendors. Many are left trying to manage security tools without … [Read more…]
DEERFIELD, Ill.–(BUSINESS WIRE)–TerSera Therapeutics LLC, a biopharmaceutical company with a focus in oncology, rare disease, and non-opioid pain management, announced today that its collaborative research on intrathecal ziconotide (PRIALT®) prescribing patterns has been accepted for presentation at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN) taking place July 17-20, 2025, … [Read more…]
PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #Anemia—Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 INDEPENDENCE trial evaluating Reblozyl® (luspatercept-aamt) with concomitant janus kinase inhibitor (JAKi) therapy in adult patients with myelofibrosis-associated anemia receiving red blood cell (RBC) transfusions did not meet its primary endpoint of RBC transfusion independence during any consecutive 12-week period, starting within the … [Read more…]
LEHI, Utah–(BUSINESS WIRE)–Weave (NYSE: WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced it will release its financial results for the second quarter 2025 after U.S. markets close on Thursday, July 31, 2025. Company management will host a conference call and webcast at 4:30 p.m. ET … [Read more…]
HOUSTON–(BUSINESS WIRE)–PathoCare Holdings, Inc.—the parent company of medical diagnostics innovator PathoCare, LLC (a leader in the Lab-on-a-Chip non-invasive Point of Care diagnostics)—has developed a set of tests backed by a revolutionary Raman spectroscopy-based testing platform that is underpinned by 17 patents and adaptive AI. Today, the company announced that it has accepted a third-party tender … [Read more…]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the second quarter of 2025 after the close of market on Wednesday, August 6, 2025. Company management will host a conference call and webcast to discuss financial results and provide a general business … [Read more…]
MCLEAN, Va.–(BUSINESS WIRE)–Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced an agreement with athenahealth, Inc. through the company’s award-winning athenahealth® Marketplace program. Now available to athenahealth’s growing network of healthcare providers, the newly integrated CompleteVue™ … [Read more…]
ST. LOUIS, Mo.–(BUSINESS WIRE)–Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that members of its management team will be participating in the following investor conferences: Morgan Stanley Global Healthcare Conference in New York City September 8, 2025 – September 10, 2025 Bank of America … [Read more…]
TOKYO–(BUSINESS WIRE)–Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix Discovery™ (https://www.elix-inc.com/platform/), has been adopted by Eisai Co., Ltd. (Headquarters: Tokyo; hereinafter “Eisai”). Traditional drug discovery involves identifying promising compounds from vast numbers of candidates, which leads to long development timelines, high costs, … [Read more…]
